Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Rydex Srs Trust Biotechnology Fd: (MF: RYOIX)

(MF) As of Mar 26, 2015 06:06 PM ET

 Add to portfolio

$92.05 USD

-0.08 (-0.09%)

Zacks MF Rank : 3 - Hold [?]     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Feb 28, 2015

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Feb 28, 2015) 12.08
Objective Sector - Health
Peer HL MG

Zacks Premium Research for RYOIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Hold 3
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 46.20
Net Assets (Mil $) 2/28/2015 309.39
%Turnover 2/28/2015 119.00

Allocation

% of Portfolio
Large Growth 17.31
Large Value 0.00
Small Growth 14.06
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 1.21
Intermediate Bond 17.82
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 2/28/2015 % of Portfolio
Health 59.09
Services 20.90
Other 9.08
Industrial Cyclical 5.77
Technology 5.16

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 6.51 34.31
AMGEN INC 6.19 32.60
CELGENE CORP 5.38 28.34
BIOGEN IDEC INC 5.22 27.50
REGENERON PHARMACEUTICALS 3.73 19.66
ALEXION PHARMACEUTICALS I 3.51 18.48
VERTEX PHARMACEUTICALS IN 3.17 16.70
ILLUMINA INC 2.92 15.38
BIOMARIN PHARMACEUTICAL 2.14 11.26

Stock Holding % of Net Assets

As Of 12/31/2014
Total Issues 75
Avg. P/E 40.34
Avg. P/Book 5.98
Avg. EPS Growth 16.06
Avg. Market Value (Mil $) 33,876

Risk

3 Year 5 Year 10 Year
Beta 0.90 0.98 0.86
Alpha 22.67 13.58 11.32
R Squared 0.19 0.39 0.38
Std. Dev. 19.66 20.64 20.65
Sharpe 2.16 1.57 1.00